Bio Farma expands vaccine production capacity and technology mastery to strengthen Indonesia’s health independence.

Bio Farma showcases vaccine technology innovations and explores strategic partnerships to strengthen Indonesia’s pharmaceutical industry at DTIIF 2026.

Bio Farma wins the 2026 Primaniyarta Award for FTA utilization, recognizing its contribution to Indonesia’s export growth.

Bio Farma and 23 Century Medical Group explore collaboration on stem cell and secretome product registration and distribution in Indonesia.